Article Information
- Received August 20, 2002
- Revision received November 23, 2002
- Accepted December 5, 2002
- First published February 15, 2003.
- Version of record published February 15, 2003.
Author Information
Author contributions
Disclosures
- Received August 20, 2002.
- Revision received November 23, 2002.
- Accepted December 5, 2002.
This work was entirely supported by Johnson & Johnson Pharmaceutical Research and Development. We thank Curt Mazur and Brian Lord for assistance with the pharmacokinetic study, and Dr. Geoffrey Abbott for helpful discussions during manuscript preparation.
Correspondence should be addressed to Dr. S. R. Chaplan, Johnson & Johnson Pharmaceutical Research and Development, 3210 Merryfield Row, San Diego, CA 92121. E-mail: schaplan{at}prdus.jnj.com.
A. A. Velumian's present address: Toronto Western Hospital, Toronto Western Research Institute, McLaughlin Pavilion, Room 12-411, 399 Bathurst Street, Toronto, Ontario M5T 2S8 Canada.
M. P. Butler's present address: Department of Integrative Biology, University of California, Berkeley, 3060 Valley Life Sciences Building 3140, Berkeley, CA 94720-3140.
Online Impact